skip to content
Making medicines affordable : a national imperative Preview this item
ClosePreview this item
Checking...

Making medicines affordable : a national imperative

Author: Norman R Augustine; Guruprasad Madhavan; Sharyl J Nass; National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Ensuring Patient Access to Affordable Drug Therapies,
Publisher: Washington, D.C. : National Academies Press, [2017] ©2017
Series: Consensus study report.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Additional Physical Format: Print version:
National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Ensuring Patient Access to Affordable Drug Therapies.
Making medicines affordable.
Washington, DC : National Academies Press, [2017]
(DLC) 2018931964
(OCoLC)1021804288
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Norman R Augustine; Guruprasad Madhavan; Sharyl J Nass; National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Ensuring Patient Access to Affordable Drug Therapies,
ISBN: 9780309468060 030946806X
OCLC Number: 1016164641
Description: 1 online resource (1 PDF file (xxviii, 206 pages)) : color illustrations.
Contents: The affordability conundrum --
Complexity in action --
Factors influencing affordability --
Strategies to improve affordability and availability --
References --
Appendices. A Dissenting View: Michael Rosenblatt and Henri Termeer --
A Minority Perspective: Rena Conti, Stacie Dusetzina, Martha Gaines, Rebekah Gee, Victoria Hale, Peter Sands, and Alan Weil.
Series Title: Consensus study report.
Responsibility: Norman R. Augustine, Guru Madhavan, and Sharyl J. Nass, editors ; Committee on Ensuring Patient Access to Affordable Drug Therapies, Board on Health Care Services, Health and Medicine Division ; a consensus study report of the National Academies of Sciences, Engineering, Medicine.

Abstract:

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicines--and health care at large--more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugs--coupled with the broader trends in overall health care costs--is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/1016164641> # Making medicines affordable : a national imperative
    a schema:MediaObject, schema:CreativeWork, schema:Book ;
    library:oclcnum "1016164641" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/dcu> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/4746314041#Topic/pharmaceutical_policy_united_states> ; # Pharmaceutical policy--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/4746314041#Topic/pharmaceutical_preparations_economics> ; # Pharmaceutical Preparations--economics
    schema:about <http://experiment.worldcat.org/entity/work/data/4746314041#Topic/health_services_accessibility_economics> ; # Health Services Accessibility--economics
    schema:about <http://experiment.worldcat.org/entity/work/data/4746314041#Topic/pharmaceutical_policy> ; # Pharmaceutical policy
    schema:about <http://experiment.worldcat.org/entity/work/data/4746314041#Place/united_states> ; # United States.
    schema:about <http://experiment.worldcat.org/entity/work/data/4746314041#Topic/drugs_prices_united_states> ; # Drugs--Prices--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/4746314041#Topic/health_policy> ; # Health Policy
    schema:about <http://experiment.worldcat.org/entity/work/data/4746314041#Topic/drugs_prices> ; # Drugs--Prices
    schema:about <http://experiment.worldcat.org/entity/work/data/4746314041#Topic/health_services_accessibility_economic_aspects_united_states> ; # Health services accessibility--Economic aspects--United States
    schema:about <http://experiment.worldcat.org/entity/work/data/4746314041#Topic/drug_costs> ; # Drug Costs
    schema:bookFormat schema:EBook ;
    schema:contributor <http://experiment.worldcat.org/entity/work/data/4746314041#Organization/national_academies_of_sciences_engineering_and_medicine_u_s_committee_on_ensuring_patient_access_to_affordable_drug_therapies> ; # National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Ensuring Patient Access to Affordable Drug Therapies,
    schema:copyrightYear "2017" ;
    schema:datePublished "2017" ;
    schema:description "The affordability conundrum -- Complexity in action -- Factors influencing affordability -- Strategies to improve affordability and availability -- References -- Appendices. A Dissenting View: Michael Rosenblatt and Henri Termeer -- A Minority Perspective: Rena Conti, Stacie Dusetzina, Martha Gaines, Rebekah Gee, Victoria Hale, Peter Sands, and Alan Weil."@en ;
    schema:description "Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicines--and health care at large--more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugs--coupled with the broader trends in overall health care costs--is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care."@en ;
    schema:editor <http://experiment.worldcat.org/entity/work/data/4746314041#Person/madhavan_guruprasad> ; # Guruprasad Madhavan
    schema:editor <http://experiment.worldcat.org/entity/work/data/4746314041#Person/augustine_norman_r> ; # Norman R. Augustine
    schema:editor <http://experiment.worldcat.org/entity/work/data/4746314041#Person/nass_sharyl_j> ; # Sharyl J. Nass
    schema:exampleOfWork <http://worldcat.org/entity/work/id/4746314041> ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://experiment.worldcat.org/entity/work/data/4746314041#Series/consensus_study_report> ; # Consensus study report.
    schema:isSimilarTo <http://www.worldcat.org/oclc/1021804288> ;
    schema:name "Making medicines affordable : a national imperative"@en ;
    schema:productID "1016164641" ;
    schema:url <https://doi.org/10.17226/24946> ;
    schema:url <https://www.ncbi.nlm.nih.gov/books/NBK493094> ;
    schema:url <https://www.nap.edu/24946> ;
    schema:url <http://www.ncbi.nlm.nih.gov/books/NBK493094/> ;
    schema:url <http://public.ebookcentral.proquest.com/choice/publicfullrecord.aspx?p=5319970> ;
    schema:workExample <http://worldcat.org/isbn/9780309468060> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/1016164641> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/4746314041#Organization/national_academies_of_sciences_engineering_and_medicine_u_s_committee_on_ensuring_patient_access_to_affordable_drug_therapies> # National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Ensuring Patient Access to Affordable Drug Therapies,
    a schema:Organization ;
    schema:name "National Academies of Sciences, Engineering, and Medicine (U.S.). Committee on Ensuring Patient Access to Affordable Drug Therapies," ;
    .

<http://experiment.worldcat.org/entity/work/data/4746314041#Person/augustine_norman_r> # Norman R. Augustine
    a schema:Person ;
    schema:familyName "Augustine" ;
    schema:givenName "Norman R." ;
    schema:name "Norman R. Augustine" ;
    .

<http://experiment.worldcat.org/entity/work/data/4746314041#Person/madhavan_guruprasad> # Guruprasad Madhavan
    a schema:Person ;
    schema:familyName "Madhavan" ;
    schema:givenName "Guruprasad" ;
    schema:name "Guruprasad Madhavan" ;
    .

<http://experiment.worldcat.org/entity/work/data/4746314041#Person/nass_sharyl_j> # Sharyl J. Nass
    a schema:Person ;
    schema:familyName "Nass" ;
    schema:givenName "Sharyl J." ;
    schema:name "Sharyl J. Nass" ;
    .

<http://experiment.worldcat.org/entity/work/data/4746314041#Place/united_states> # United States.
    a schema:Place ;
    schema:name "United States." ;
    .

<http://experiment.worldcat.org/entity/work/data/4746314041#Series/consensus_study_report> # Consensus study report.
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/1016164641> ; # Making medicines affordable : a national imperative
    schema:name "Consensus study report." ;
    schema:name "Consensus study report" ;
    .

<http://experiment.worldcat.org/entity/work/data/4746314041#Topic/drugs_prices_united_states> # Drugs--Prices--United States
    a schema:Intangible ;
    schema:name "Drugs--Prices--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4746314041#Topic/health_services_accessibility_economic_aspects_united_states> # Health services accessibility--Economic aspects--United States
    a schema:Intangible ;
    schema:name "Health services accessibility--Economic aspects--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4746314041#Topic/health_services_accessibility_economics> # Health Services Accessibility--economics
    a schema:Intangible ;
    schema:name "Health Services Accessibility--economics"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4746314041#Topic/pharmaceutical_policy> # Pharmaceutical policy
    a schema:Intangible ;
    schema:name "Pharmaceutical policy"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4746314041#Topic/pharmaceutical_policy_united_states> # Pharmaceutical policy--United States
    a schema:Intangible ;
    schema:name "Pharmaceutical policy--United States"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/4746314041#Topic/pharmaceutical_preparations_economics> # Pharmaceutical Preparations--economics
    a schema:Intangible ;
    schema:name "Pharmaceutical Preparations--economics"@en ;
    .

<http://worldcat.org/isbn/9780309468060>
    a schema:ProductModel ;
    schema:isbn "030946806X" ;
    schema:isbn "9780309468060" ;
    .

<http://www.worldcat.org/oclc/1021804288>
    a schema:CreativeWork ;
    rdfs:label "Making medicines affordable." ;
    schema:description "Print version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/1016164641> ; # Making medicines affordable : a national imperative
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.